☰

Martin E. Nau - Publications

Affiliations: 
Henry M Jackson Foundation for the Advancement of Military Medicine,, Bethesda, MD, United States 
Tree Info Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Furusato B, Tsunoda T, Shaheduzzaman S, Nau ME, Vahey M, Petrovics G, McLeod DG, Naito S, Shirasawa S, Srivastava S, Sesterhenn IA. Osteoblast-specific factor 2 expression in prostate cancer-associated stroma: identification through microarray technology. Urology. 75: 768-72. PMID 20035976 DOI: 10.1016/j.urology.2009.10.026  0.354
2008 Vahey MT, Wang Z, Su Z, Nau ME, Krambrink A, Skiest DJ, Margolis DM. CD4+ T-cell decline after the interruption of antiretroviral therapy in ACTG A5170 is predicted by differential expression of genes in the ras signaling pathway. Aids Research and Human Retroviruses. 24: 1047-66. PMID 18724805 DOI: 10.1089/Aid.2008.0059  0.302
2007 Vahey MT, Ockenhouse CF, Wang Z, Yalley-Ogunro J, Greenhouse J, Nau ME, Lewis MG. Impact of antiretroviral treatment on gene expression in peripheral blood mononuclear cells from SIVmac251-infected macaques. The Journal of Infectious Diseases. 196: 384-93. PMID 17597453 DOI: 10.1086/519388  0.394
2007 Shaheduzzaman S, Vishwanath A, Furusato B, Cullen J, Chen Y, Bañez L, Nau M, Ravindranath L, Kim KH, Mohammed A, Chen Y, Ehrich M, Srikantan V, Sesterhenn IA, McLeod D, et al. Silencing of Lactotransferrin expression by methylation in prostate cancer progression. Cancer Biology & Therapy. 6: 1088-95. PMID 17568188  0.409
2007 Shaheduzzaman S, Vishwanath A, Furusato B, Cullen J, Chen Y, Bañez LL, Nau M, Ravindranath L, Kim K, Mohamed A, Chen Y, Ehrich M, Srikantan V, Sesterhenn IA, McLeod DG, et al. 669: Effects and Mechanisms of Frequent Downregulation of Lactotransferrin (LTF) in Prostate Cancer The Journal of Urology. 177: 224-225. DOI: 10.1016/S0022-5347(18)30909-1  0.386
2006 Gao CL, Shaheduzzaman S, Petrovics G, Furusato B, Nau M, Ravindranath L, Chen Y. 820: Hippi Expression Associates with Prostate Cancer Prognosis The Journal of Urology. 175: 264-265. DOI: 10.1016/S0022-5347(18)33056-8  0.429
2006 Bañez LL, Shaheduzzaman S, Vishwanath A, Furusato B, Nau M, Ravindranath L, Chen Y, Chen Y, Cullen J, Sesterhenn IA, Vahey M, McLeod DG, Petrovics G, Srikantan V, Srivastava S. 435: Lactotransferrin: A Frequent Expression Down-Regulation in Prostate Cancer The Journal of Urology. 175: 141-141. DOI: 10.1016/S0022-5347(18)32691-0  0.434
2006 Petrovics G, Liu A, Shaheduzzaman S, Furasato B, Sun C, Chen Y, Nau M, Ravindranath L, Dobi A, Srikantan V, Sesterhenn IA, McLeod DG, Vahey M, Moul JW, Srivastava S. Frequent Overexpression of ETS-Related Gene-1 (ERG1) in Prostate Cancer Transcriptome The Journal of Urology. 175: 1706-1707. DOI: 10.1016/S0022-5347(06)00095-4  0.451
2005 Petrovics G, Liu A, Shaheduzzaman S, Furusato B, Furasato B, Sun C, Chen Y, Nau M, Ravindranath L, Chen Y, Dobi A, Srikantan V, Sesterhenn IA, McLeod DG, Vahey M, et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene. 24: 3847-52. PMID 15750627 DOI: 10.1038/sj.onc.1208518  0.432
2005 Srikantan V, Petrovics G, Liu A, Shaheduzzaman S, Furasato B, Sun C, Chen Y, Nau ME, Ravindranath L, Chen Y, Dobi A, Sesterhenn IA, McLeod DG, Vahey M, Moul JW, et al. 229: Frequent Overexpression of ETS-related Gene (ERG) in Prostate Cancer Transcriptome Reveals its Diagnostic and Prognostic Potential The Journal of Urology. 173: 63-63. DOI: 10.1016/S0022-5347(18)34494-X  0.45
2005 Shaheduzzaman S, Furusato B, Srikantan V, Petrovics G, Nau ME, Valladares M, Zhang W, Sesterhenn IA, Vahey M, McLeod DG, Moul JW, Srivastava S. 226: Gene Expression / Biochemical Pathway Signatures of Prostate Cancer Cells of Patients with High Risk and Moderate Risk Progression of Disease Journal of Urology. 173: 62-62. DOI: 10.1016/S0022-5347(18)34491-4  0.432
2004 Shaheduzzaman S, Furusato B, Srikantan V, Petrovics G, Nau M, Valladares M, Zhang W, Sun L, Sesterhenn IA, McLeod DG, Moul JW, Chen Y, Vahey M, Srivastava S. 1102: Gene Expression Signatures in Benign and Malignant Epithelial Cells of Prostate Cancer Patients with “Aggressive” and “Non-Aggressive” Disease Journal of Urology. 171: 290-291. DOI: 10.1016/S0022-5347(18)38339-3  0.481
2003 Vahey MT, Nau ME, Taubman M, Yalley-Ogunro J, Silvera P, Lewis MG. Patterns of gene expression in peripheral blood mononuclear cells of rhesus macaques infected with SIVmac251 and exhibiting differential rates of disease progression. Aids Research and Human Retroviruses. 19: 369-87. PMID 12803996 DOI: 10.1089/088922203765551728  0.417
2002 Segawa T, Nau ME, Xu LL, Chilukuri RN, Makarem M, Zhang W, Petrovics G, Sesterhenn IA, McLeod DG, Moul JW, Vahey M, Srivastava S. Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene. 21: 8749-58. PMID 12483528 DOI: 10.1038/sj.onc.1205992  0.35
2002 Vahey MT, Nau ME, Jagodzinski LL, Yalley-Ogunro J, Taubman M, Michael NL, Lewis MG. Impact of viral infection on the gene expression profiles of proliferating normal human peripheral blood mononuclear cells infected with HIV type 1 RF. Aids Research and Human Retroviruses. 18: 179-92. PMID 11839152 DOI: 10.1089/08892220252781239  0.418
2000 Nau ME, Emerson LR, Martin RK, Kyle DE, Wirth DF, Vahey M. Technical assessment of the affymetrix yeast expression GeneChip YE6100 platform in a heterologous model of genes that confer resistance to antimalarial drugs in yeast. Journal of Clinical Microbiology. 38: 1901-8. PMID 10790119 DOI: 10.1128/Jcm.38.5.1901-1908.2000  0.345
Show low-probability matches.